We Know Nano

We Know Nano

Ardena’s first nanomedicine symposium brings together leading scientists, clinicians, and industry experts to discuss the latest advances in nanomedicine. Over two days, you will hear from  and engage directly with –  international key opinion leaders, industry innovators, and Ardena’s own nanomedicine experts

WHERE

Location

Oss, The Netherlands

WHEN

Date

15–16 September 2026

WHO

Audience

C-level executives, CMC experts, and senior scientists from biotech, pharma, and academia

Speakers

Christian Schröter

Christian Schröter

Chief Operating Officer & Managing Director, Topas Therapeutics GmbH

Dr. Glenn Meyer, PhD

Dr. Glenn Meyer, PhD

CMC, Product Development, Peptinovo Biopharma

Morten Just Petersen

Morten Just Petersen

Chief Development Officer, MonTa Biosciences

Prof. Dr. Dr. Twan Lammers

Prof. Dr. Dr. Twan Lammers

Department of Nanomedicine and Theranostics Institute for Experimental Molecular Imaging RWTH Aachen University Clinic

Mark van Eldijk

Mark van Eldijk

Business Unit Director Nanomedicines

Scientific focus areas

Nanomedicines in clinical development

Bioconjugation

mRNA / LNP formulation strategies

Analytical characterisation of complex modalities

What's included for participants

Selected participants receive

Apply via form below

  • Full two-day symposium access

  • Certificate of attendance

  • Networking dinner and welcome reception

Apply to Attend

Places are limited and participants are selected based on scientific background and relevance to the symposium topics. Once confirmed, hotel accommodation is taken care of — just show up ready to talk science.

Selective attendance. Submitting this form is an application, not a confirmed registration. Our team reviews each submission and will contact you within a few working days to confirm your place.